INDEPSO

How much of the peritoneal surface are we really seeing?

In CRS, we focus on removing visible disease.

But what about the spaces we don't routinely explore?

At OGP 2026, Dr. Aditi Bhatt 🇮🇳 takes a closer look at:

“Revised Classification of Peritonectomy Procedures & Exploration of Occult Peritoneal Spaces.”

Can redefining peritonectomy and understanding occult spaces improve the completeness of cytoreduction?

A surgical anatomy discussion with implications far beyond anatomy.

📍 Pune | 📅 18–19 Sept 2026
🎟️ Register:
ogp2026.com/registration/d…

#OGP2026 #CRS #HIPEC #PeritonealSurfaceOncology #Peritonectomy #SurgicalOncology

Advanced pseudomyxoma peritonei isn't just about removing more disease—it's about making the right decisions.

When is surgery still worthwhile?
Can complete cytoreduction be achieved?
How do disease burden, anatomy, patient fitness, and biology influence outcomes?

Join Dr. Avanish Saklani as moderator for a high-impact Panel Discussion on Advanced Pseudomyxoma Peritonei at OGP 2026.
Hear leading experts discuss challenging cases, controversial scenarios, and the practical decision-making that defines modern CRS & HIPEC.
If you manage patients with peritoneal surface malignancies, this is a discussion you won't want to miss.
📍 OGP 2026 | Pune
📅 17–19 September 2026
🎟️ Register now:
ogp2026.com/registration/d…
#OGP2026 #PMP #PseudomyxomaPeritonei #CRS #HIPEC #PeritonealSurfaceOncology #PanelDiscussion #AvanishSaklani #SurgicalOncology #CancerSurgery

@zeebausofi @writeslkpushkin @vivekanandkem @Bhandoria @Snioncosurgeon1

When pseudomyxoma peritonei is extensive, every decision carries weight.

How much disease is too much?
When should surgery be attempted?
How do we balance radicality with safety?
And what separates a successful cytoreduction from an incomplete one?
These are the questions that define outcomes—not just operative skill.
At OGP 2026, we're privileged to welcome Prof. @glehenolivier 🇫🇷, one of the world's leading authorities in Peritoneal Surface Oncology, for a thought-provoking session:
"Huge PMP: Critical Clinical Decisions."

Drawing on decades of experience in CRS & HIPEC, Prof. Glehen will share practical insights into managing some of the most challenging cases in surgical oncology, where anatomy is distorted, decisions are complex, and surgical judgement is everything.

Whether you're a surgical oncologist, gynecologic oncologist, medical oncologist, or trainee, this is a session you won't want to miss.

📍 OGP 2026 | Pune, India
📅 17–19 September 2026

🎟️ Register now:
ogp2026.com/registration/d…

#OGP2026 #PMP #PseudomyxomaPeritonei #CRS #HIPEC #PeritonealSurfaceOncology #OlivierGlehen #SurgicalOncology #CancerSurgery #MedicalEducation

@zeebausofi @PSOGI_EC

Can minimally invasive surgery redefine gynecologic oncology?

Join Prof. @artemstepanyan 🇦🇲 as he discusses:
"Minimally Invasive Surgery in Gynecological Cancers: Scope and Beyond."
Where does MIS stand today? What does the evidence support? And where is the field headed?

📍 OGP 2026 | Pune
📅 17–19 Sept 2026

🎟️ Register now:
ogp2026.com/registration/d…
#OGP2026 #GynecologicOncology #MIS #SurgicalOncology #ArtemStepanyan #RegisterNow
@zeebausofi @IASOmasterclass

How far is too far?

As the boundaries of cytoreductive surgery continue to evolve, one question remains at the heart of every operation:

Who should we operate on?

Join Prof. @LanaBijelicMD as she explores one of the most thought-provoking topics in Peritoneal Surface Oncology:

Selecting Patients for Cytoreductive Surgery: Extending Indications

Discover how evidence, experience, and surgical judgement come together to define the right patient for the right operation.

If you're involved in CRS & HIPEC, this is a session you won't want to miss.

📍 OGP 2026 | Pune
📅 17–19 September 2026
🎟️ Secure your seat today and learn from one of the world's foremost experts in Peritoneal Surface Oncology.
👉 ogp2026.com/registration/d…

#OGP2026 #CRS #HIPEC #PeritonealSurfaceOncology #SurgicalOncology #LanaBijelic #CancerSurgery #MedicalEducation #RegisterNow
@zeebausofi